52 related articles for article (PubMed ID: 1722636)
1. [Clinical evaluation of serum basic fetoprotein in patients with urogenital malignancies and renal transplantation].
Seguchi T; Sugao H; Takahara S; Nakano E; Ishibashi M; Sonoda T
Hinyokika Kiyo; 1991 Nov; 37(11):1475-9. PubMed ID: 1722636
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (1) Clinical usefulness of BFP].
Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2107-13. PubMed ID: 2456039
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers].
Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2115-23. PubMed ID: 2456040
[TBL] [Abstract][Full Text] [Related]
4. Correlation of serum basic fetoprotein with acute rejection in kidney transplantation.
Seguchi T; Nakano E; Kameoka H; Takahara S; Namiki M; Ishibashi M; Okuyama A
Clin Transplant; 1994 Feb; 8(1):30-3. PubMed ID: 8136564
[TBL] [Abstract][Full Text] [Related]
5. Urinary basic fetoprotein in the diagnosis and follow-up of patients with urothelial carcinoma.
Kigure T; Wakayama Y; Satoh Y; Fujieda N; Yoshida K; Harada T
Cancer; 1996 Apr; 77(8):1529-34. PubMed ID: 8608539
[TBL] [Abstract][Full Text] [Related]
6. Clinical-evaluation of serum basic fetoprotein as a marker in urogenital malignant-tumors.
Gotoh A; Harada K; Gohji K; Arakawa S; Kamidono S
Oncol Rep; 1995 Jan; 2(1):49-53. PubMed ID: 21597687
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of urinary basic fetoprotein and the BTA test for detection of bladder cancer].
Imamura M; Inoue K; Megumi Y; Nishimura M; Ohmori K; Nishimura K
Hinyokika Kiyo; 2000 Oct; 46(10):705-9. PubMed ID: 11215195
[TBL] [Abstract][Full Text] [Related]
8. [Basic fetoprotein (BFP)].
Ishii M; Seino Y; Urabe T; Hattori N
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1402-9. PubMed ID: 2425742
[TBL] [Abstract][Full Text] [Related]
9. [Clinical investigation of basic fetoprotein (BFP) and carcinoembryonic antigen (CEA) in stomach cancer and lung cancer].
Kanda Y; Ishii M
Gan No Rinsho; 1985 May; 31(6 Suppl):600-5. PubMed ID: 2411961
[TBL] [Abstract][Full Text] [Related]
10. [The clinical usefulness of urinary basic fetoprotein (BFP) in patients with urological malignancies].
Tsujii T; Yonese J; Kojima S; Tari K; Ishii M; Seino Y
Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):829-34. PubMed ID: 1698231
[TBL] [Abstract][Full Text] [Related]
11. [A clinical study on the tumor associated antigen CA50 in the monitoring of genitourinary malignancies].
Li CL; Xu BZ; Chen ZZ
Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):148-51. PubMed ID: 7924868
[TBL] [Abstract][Full Text] [Related]
12. Pediatric kidney transplantation is safe and available for patients with urological anomalies as well as those with primary renal diseases.
Morita K; Iwami D; Hotta K; Shimoda N; Miura M; Watarai Y; Hoshii S; Obikane K; Nakashima T; Sasaki S; Nonomura K
Pediatr Transplant; 2009 Mar; 13(2):200-5. PubMed ID: 18662371
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of serum S100ao protein in patients with urogenital diseases and healthy volunteers].
Kikuchi T; Morita T; Hashimoto S; Hara Y; Moriguchi H; Ishikawa S; Kobayashi Y; Ishiyama S; Goto K; Tozuka K
Hinyokika Kiyo; 1990 Oct; 36(10):1117-23. PubMed ID: 2264539
[TBL] [Abstract][Full Text] [Related]
14. DNA fragmentation in acute and chronic rejection after renal transplantation.
Ott U; Aschoff A; Fünfstück R; Jirikowski G; Wolf G
Transplant Proc; 2007; 39(1):73-7. PubMed ID: 17275477
[TBL] [Abstract][Full Text] [Related]
15. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
Hamami G
Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
[TBL] [Abstract][Full Text] [Related]
16. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
Sanada S; Ogura K; Kiriyama T; Yoshida O
Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
[TBL] [Abstract][Full Text] [Related]
17. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum tumor necrosis factor alpha and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases.
Sonkar GK; ; Singh RG
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1000-4. PubMed ID: 19861860
[TBL] [Abstract][Full Text] [Related]
19. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
20. Serum basic fetoprotein in patients with renal cell carcinoma.
Gohji K; Ishii M; Nagata H; Matsumoto O; Kamidono S
Cancer; 1990 Mar; 65(6):1405-11. PubMed ID: 1689608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
